Hurtado-Andrade H

Language: Spanish
References: 19
Page: 302-304
PDF size: 34.83 Kb.

Text Extraction

No abstract

REFERENCES

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J 1954; 2(4884): 375-8.

2. Naber AHJ, de Jong DJ. Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials. Neth J Med 2003; 61: 105-10.

3. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894-8.

4. Jalan KN, Sircus W, Card WI, Falconer, Bruce CB. An experience of ulcerative colitis. Gastroenterology 1969; 57: 68-82.

5. Lennard-Jones JE, Ritchie JE, Hilder W, Spicer CC. Assessment of severity in colitis: a preliminary study. Gut 1975; 16: 579-84.

6. Choquet A, Yamamoto-Furusho JK, Vargas-Vorácková F, Uscanga L, Reyes E, Takahashi-Monroy T. Predictores de colectomía en enfermos con colitis ulcerativa crónica inespecífica (CUCI). Análisis de una cohorte de 184 casos. Rev Invest Clin 2004; 56(1): 11-15.

7. Caprilli R, Frieri G, Latella G, Vernia P, Frieri G. Multiple organ dysfunction in ulcerative colitis. Am J Gastroenterol 2000; 95: 1258-62.

8. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut 1969; 38: 905-10.

9. Caprilli R, Vernia P, Colaneri O, Torsoli A. Blood pH: a test for assessment of severity on proctocolitis. Gut 1976; 17: 763-9.

10. Buckell NA, Williams GT, Bartram CI, Lennard-Jones JE. Depth of ulceration in acute colitis. Correlation with outcome and clinical and radiological features. Gastroenterology 1980; 79: 19-25.

11. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53: 1479-84.

12. Hallert C, Bjorck I, Nyman M, et al. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 2003; 9: 116-21.

13. Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15(6): 697-8.

14. Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Int Med 1993; 118: 540-9.

15. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. The Cochrane Library. The Cochrane Collaboration; 2007, Vol. 2.

16. Sulfasalazine intolerance: a retrospective study of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 1982; 17: 389-93.

17. Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A, Befrits R, et al. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomized, double blind, placebo controlled study. Gut 2005; 54(7): 960-5.

18. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2003; 3: CD000543.

19. Cohen RD, Woseth DM, Thisted RA, et al. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000; 95: 1263-76.